Newsletters and Deep Dive digital magazine
From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitised one – a process which has been massively accelerated by the Covid pan
The subject of man flu has long been viewed with scepticism by those in the life sciences industry.
Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find.
Digital transformation is taking root in every major industry, and healthcare and life sciences are no exception.
As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022?
After two FDA rejections for non-alcoholic steatohepatitis (NASH) therapy obeticholic acid (OCA), Intercept Pharma has agreed to be taken over by Italian drugmaker Alfasig
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho